Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$8.59 - $20.77 $36 Million - $87 Million
-4,189,421 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$15.52 - $35.65 $681,576 - $1.57 Million
-43,916 Reduced 1.04%
4,189,421 $79.3 Million
Q4 2021

Feb 11, 2022

BUY
$28.89 - $35.33 $1.27 Million - $1.55 Million
43,884 Added 1.05%
4,233,337 $149 Million
Q3 2021

Nov 03, 2021

BUY
$35.66 - $42.94 $3.6 Million - $4.34 Million
100,982 Added 2.47%
4,189,453 $153 Million
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $2.13 Million - $3.53 Million
89,872 Added 2.25%
4,088,471 $161 Million
Q1 2021

May 12, 2021

BUY
$27.01 - $36.8 $12.8 Million - $17.4 Million
472,641 Added 13.4%
3,998,599 $113 Million
Q4 2020

Feb 16, 2021

BUY
$27.51 - $34.36 $6.99 Million - $8.72 Million
253,924 Added 7.76%
3,525,958 $113 Million
Q3 2020

Nov 16, 2020

BUY
$25.8 - $34.61 $19.9 Million - $26.7 Million
770,058 Added 30.78%
3,272,034 $106 Million
Q2 2020

Aug 11, 2020

BUY
$17.65 - $28.05 $2.3 Million - $3.65 Million
130,051 Added 5.48%
2,501,976 $69 Million
Q1 2020

May 14, 2020

BUY
$15.19 - $29.51 $13.1 Million - $25.5 Million
865,350 Added 57.44%
2,371,925 $42.3 Million
Q4 2019

Feb 13, 2020

BUY
$17.17 - $25.95 $10.5 Million - $15.8 Million
610,205 Added 68.08%
1,506,575 $37.8 Million
Q3 2019

Nov 14, 2019

BUY
$17.84 - $22.69 $508,386 - $646,596
28,497 Added 3.28%
896,370 $16 Million
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $1.12 Million - $1.62 Million
50,882 Added 6.23%
867,873 $19.1 Million
Q1 2019

May 15, 2019

SELL
$21.27 - $30.58 $287,761 - $413,716
-13,529 Reduced 1.63%
816,991 $25 Million
Q4 2018

Feb 14, 2019

BUY
$23.09 - $37.69 $7.44 Million - $12.1 Million
322,245 Added 63.4%
830,520 $19.2 Million
Q3 2018

Nov 14, 2018

BUY
$26.55 - $34.38 $13.5 Million - $17.5 Million
508,275 New
508,275 $16.4 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.